IART Stock Overview
Manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 3/6 |
Past Performance | 1/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Integra LifeSciences Holdings Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$20.85 |
52 Week High | US$45.42 |
52 Week Low | US$20.76 |
Beta | 1.11 |
11 Month Change | -33.47% |
3 Month Change | -25.85% |
1 Year Change | -50.79% |
33 Year Change | -71.53% |
5 Year Change | -64.35% |
Change since IPO | 350.81% |
Recent News & Updates
Recent updates
Is Integra LifeSciences Holdings (NASDAQ:IART) A Risky Investment?
Aug 21At US$29.14, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely?
Jul 01Integra LifeSciences Still Underperforming As Manufacturing Issues Linger
Jun 21Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Intrinsic Value Is Potentially 40% Above Its Share Price
May 28Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Stalled
Feb 27We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Feb 11Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Jan 14Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Price In Tune With Earnings
Dec 31Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 46% Discount?
Dec 03Does Integra LifeSciences Holdings (NASDAQ:IART) Have A Healthy Balance Sheet?
Nov 06Integra LifeSciences Holdings (NASDAQ:IART) Hasn't Managed To Accelerate Its Returns
Oct 24Is Now An Opportune Moment To Examine Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Sep 22Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 38% Discount?
Aug 15Returns On Capital At Integra LifeSciences Holdings (NASDAQ:IART) Have Hit The Brakes
Jul 03Is There Now An Opportunity In Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Jun 19Estimating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
May 05These 4 Measures Indicate That Integra LifeSciences Holdings (NASDAQ:IART) Is Using Debt Reasonably Well
Apr 07Integra LifeSciences Holdings (NASDAQ:IART) Is Experiencing Growth In Returns On Capital
Mar 26At US$52.61, Is It Time To Put Integra LifeSciences Holdings Corporation (NASDAQ:IART) On Your Watch List?
Mar 14Does Integra LifeSciences Holdings (NASDAQ:IART) Deserve A Spot On Your Watchlist?
Feb 27Calculating The Fair Value Of Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Feb 02We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Jan 05Here's What To Make Of Integra LifeSciences Holdings' (NASDAQ:IART) Decelerating Rates Of Return
Dec 21When Should You Buy Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Dec 08Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Trading At A 42% Discount?
Oct 19We Think Integra LifeSciences Holdings (NASDAQ:IART) Can Stay On Top Of Its Debt
Oct 05Integra LifeSciences: Wide Dislocation In Fundamentals Vs. Market Value
Sep 13Shareholder Returns
IART | US Medical Equipment | US Market | |
---|---|---|---|
7D | -3.8% | 2.4% | 3.1% |
1Y | -50.8% | 9.8% | 25.4% |
Return vs Industry: IART underperformed the US Medical Equipment industry which returned 11.2% over the past year.
Return vs Market: IART underperformed the US Market which returned 25.6% over the past year.
Price Volatility
IART volatility | |
---|---|
IART Average Weekly Movement | 7.2% |
Medical Equipment Industry Average Movement | 8.2% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.0% |
10% least volatile stocks in US Market | 3.2% |
Stable Share Price: IART's share price has been volatile over the past 3 months.
Volatility Over Time: IART's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1989 | 3,946 | Jan De Witte | www.integralife.com |
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services.
Integra LifeSciences Holdings Corporation Fundamentals Summary
IART fundamental statistics | |
---|---|
Market cap | US$1.67b |
Earnings (TTM) | US$23.65m |
Revenue (TTM) | US$1.57b |
68.4x
P/E Ratio1.0x
P/S RatioIs IART overvalued?
See Fair Value and valuation analysisEarnings & Revenue
IART income statement (TTM) | |
---|---|
Revenue | US$1.57b |
Cost of Revenue | US$627.06m |
Gross Profit | US$939.44m |
Other Expenses | US$915.80m |
Earnings | US$23.65m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.30 |
Gross Margin | 59.97% |
Net Profit Margin | 1.51% |
Debt/Equity Ratio | 119.1% |
How did IART perform over the long term?
See historical performance and comparison